Article
Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
Pharmacology, biochemistry, and behavior - 1 Feb 2009
Labrie Viviane, Clapcote Steven J, Roder John C
Abstract excerpt
Several compounds that promote activation of the N-methyl-d-aspartate receptor (NMDAR) glycine site have been proposed as treatments for schizophrenia, but the impact of these putative antipsychotics on anxiety remains unclear. In this study, we employed genetic and pharmacological mouse models of altered NMDAR glycine site function to examine the effects of these proposed treatments in unconditioned tests of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
